Surging global incidence of coronary artery disease, expanding clinical adoption of minimally invasive percutaneous coronary interventions (PCI), and continuous biomaterial advancements in biocompatible polymer matrices are driving rapid growth across the global Drug Eluting Stent market. Drug-eluting stents (DES)—comprising cobalt-chromium and platinum-chromium metallic platforms,...
